Controversy remains on the differences in postprandial actions of insulin glulisine and lispro. The aim of this study was to define the differences in the efficacy of these two insulin analogues on PPG.The study subjects were 20 in-hospital patients with type 2 diabetes mellitus (T2DM). Plasma...
摘要: Aims: To compare the end-organ metabolic effects of insulin glulisine (glulisine), insulin lispro (lispro) and regular human insulin (RHI) in patients with type 1 diabetes mellitus.关键词:euglycaemic glucose clamp glulisine lispro ...
Insulin glulisine is associated with a faster glucose-lowering effect than RHI, but shows a similar level of glucose disposal overall, in patients with type 1 or type 2 diabetes. Insulin glulisine and insulin lispro appear similar with regard to speed and extent of glucose lowering in patients ...
Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled TrialingentaconnectDiabetes Technology & Therapeutics
Amolds S; Rave K; Hovelmann U;.Insulin glulisine has a faster onset of action compared with insulin aspart in healthy volunteers.Exp Clin Endocrinol Diabetes.2010.662-664Arnolds S, Rave K, Hovelmann U. Insulin glulisine has a faster onset of action compared with insulin aspart in healthy ...
Heise T,Nosek L,Spitzer H,et al.Insulin glulisine:a faster onset of action compared with insulin lispro. Diabetes Obesity and Metabolism . 2007Heise T, Nosek L, Spitzer H, Heinemann L, Niemoller E, Frick AD, Becker RHA. Insulin glulisi- ne: a faster onset of action compared with ...
pdb5 comparison of clinical effectiveness and safety of glulisine versus insulin lispro, aspart and regular human insulin in patients with type i and 2 diabetesdoi:10.1016/S1098-3015(10)70694-XJ WalczakE BorowiackK KolodziejJ LisJ Gierczynski...
Long‐acting insulinUltra‐rapid‐acting insulinINTRODUCTION: We compared the effects of morning administration of insulin glulisine + insulin glargine 300 U/mL (G + G300) with that of insulin lispro + insulin glargine biosimilar (L + GB). MATERIALS AND METHODS: A total of 30 patients with ...
Letter written in response to van Bon et al: `'Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial''. Diabetes Technol Ther. 2011;13:869-70....
Only studies reporting baseline-endpoint change in insulin dose, or baseline and endpoint values were included. Fourteen studies (GLU, 3; insulin aspart, 4; insulin lispro [LIS ] , 7; 5456 patients) were identified and reported baseline-endpoint change in basal and prandial insulin doses. One...